GlassScriptPhysician profile
Tatjana Benedict
NPI 1386915015
$2,298.87
in general payments reported to CMS, 2019-2025
33 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $795 · 2022: $492 · 2023: $765 · 2024: $102 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $431.11 | 2021-2023 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.07 | 2021-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $185.98 | 2021-2024 | Breztri, Farxiga |
| Amarin Pharma, INC. | $184.70 | 2021-2023 | |
| Medtronic, INC. | $173.96 | 2023 | Minimed 780g, Minimed 770g, Inpen Smart Insulin Delivery System |
| Globus Medical, INC. | $145.13 | 2025 | Excelsius Gps, Rise, Creo |
| Kowa Pharmaceuticals America, INC. | $104.22 | 2021-2022 | |
| Lilly USA, LLC | $82.23 | 2021-2023 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $67.00 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $63.37 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $61.33 | 2021-2022 | |
| Embecta Corp. | $59.47 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Amgen INC. | $51.78 | 2021-2022 | |
| Phadia US INC. | $33.28 | 2021 | |
| Janssen Pharmaceuticals, INC | $33.17 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $27.32 | 2021-2023 | Nexletol |
| Radius Health, INC. | $26.23 | 2022 | |
| Alexion Pharmaceuticals, INC. | $23.95 | 2023 | Strensiq |
| Astellas Pharma US INC | $23.92 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.58 | 2023 | |
| Averitas Pharma INC. | $22.98 | 2023 | Qutenza |
| Corcept Therapeutics | $22.61 | 2023 | Korlym |
| Biohaven Pharmaceutical Holding Company LTD. | $22.47 | 2022 | |
| Antares Pharma, INC. | $21.19 | 2023 | Tlando, Xyosted, Nocdurna |
| Edwards Lifesciences Corporation | $19.66 | 2022 | |
| Azurity Pharmaceuticals, INC. | $18.72 | 2023 | Adthyza |
| Abbvie INC. | $18.33 | 2023 | |
| Ibsa Pharma INC. | $18.02 | 2023 | Tirosint, Licart |
| Endo Pharmaceuticals INC. | $16.62 | 2023 | Aveed |
| Vivus LLC | $16.34 | 2022 | |
| Amneal Pharmaceuticals LLC | $15.58 | 2023 | Unithroid |
| Paratek Pharmaceuticals, INC. | $15.12 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tatjana Benedict listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.